3 Iconography
Access to the text (HTML) Access to the text (HTML)
PDF Access to the PDF text

Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates

Journal of the American Academy of Dermatology
Sous presse. Epreuves corrigées par l'auteur. Disponible en ligne depuis le vendredi 11 octobre 2019
Doi : 10.1016/j.jaad.2019.08.027
accepted : 10 August 2019
Prognostic value of inositol polyphosphate-5-phosphatase expression in recurrent and metastatic cutaneous squamous cell carcinoma

Connor J. Maly, BS a, Helen J.L. Cumsky, MD a, Collin M. Costello, MD a, Jessica E. Schmidt, MS a, Richard J. Butterfield, MS b, Nan Zhang, MS b, David J. DiCaudo, MD a, Steven A. Nelson, MD a, Maxwell L. Smith, MD c, Shari A. Ochoa, MD a, Christian L. Baum, MD d, Thomas H. Nagel, MD e, Mark R. Pittelkow, MD a, Aleksandar Sekulic, MD, PhD a, Aaron R. Mangold, MD a,
a Department of Dermatology, Mayo Clinic, Scottsdale, Arizona 
b Department of Health Science Research, Mayo Clinic, Scottsdale, Arizona 
c Department of Pathology, Mayo Clinic, Scottsdale, Arizona 
d Department of Dermatology, Mayo Clinic, Rochester, Minnesota 
e Department of Otolaryngology, Mayo Clinic, Scottsdale, Arizona 

Correspondence to: Aaron R. Mangold, MD, Mayo Clinic Department of Dermatology, 13400 E Shea Blvd, Scottsdale, AZ 85259.Mayo Clinic Department of Dermatology13400 E Shea BlvdScottsdaleAZ85259

Inositol polyphosphate-5-phosphatase (INPP5A) has been shown to play a role in the progression of actinic keratosis to cutaneous squamous cell carcinoma (cSCC) and the progression of localized disease to metastatic disease. Currently, no cSCC biomarkers are able to risk stratify recurrent and metastatic disease.


To determine the prognostic value of INPP5A expression in cSCC recurrent and metastatic disease.


We conducted a multicenter, single-institutional, retrospective cohort study within the Mayo Clinic Health System on the use of immunohistochemical staining to examine cSCC INPP5A protein expression in primary tumors and recurrent and metastatic disease. Dermatologists and dermatopathologists were blinded to outcome.


Low staining expression of INPP5A in recurrent and metastatic disease tumors was associated with poor overall survival (OS) (31.0 months for low versus 62.0 months for high expression; P  = .0272). A composite risk score (calculated as score of primary tumor + score of recurrent or metastatic disease tumor, with tumors with high expression scoring a zero and low expression a 1, score range 0-2) of 0 was predictive of improved OS compared with a composite risk score of ≥1 (hazard ratio 0.42, 95% confidence interval 0.21-0.84; P  = .0113).


This is a multicenter but single institution study of a white population.


Loss of INPP5A expression predicts poor OS in recurrent and metastatic disease of cSCC.

The full text of this article is available in PDF format.

Key words : IHC, immunohistochemistry, inositol polyphosphate-5-phosphatase, INPP5A, SCC, squamous cell carcinoma

Abbreviations used : BWH, CRS, cSCC, HR, HSE, INPP5A, LR, LSE, OS, SCC

 Funding sources: Supported by a Dermatology Foundation Career Development Award and the National Institutes of Health (grant no. 5R01CA179157).
 Conflicts of interest: None disclosed.
 Previously presented at the Society for Investigative Dermatology 77th annual meeting in Chicago, Illinois, May 8-11, 2019.
 Reprints not available from the authors.

© 2019  American Academy of Dermatology, Inc.@@#104156@@
EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Article Outline
You can move this window by clicking on the headline